Video

Resilience US, Inc. Capacity Update February 2024: Large Molecule

Founded in 2020, Resilience is a technology-focused biomanufacturing company dedicated to broadening access to complex medicines. With a strong network of sites across six states and one in Canada, Resilience provides innovative solutions and services for established and emerging therapies. Hear Evan Pasenello, Business Head of Biologics & Vaccines, discuss how Resilience can support your development and manufacturing programs.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Resilience US, Inc.